AIDS issues and support

Archive for May, 2011

Can STATINS be used as anti viral drugs?

Can statins be used as anti viral drugs?

I already have heard about Statins (Mevacor, Lovastatin etc) in other
therapeutic applications beyond their most trivial appliance as Cholesterol
lowering drugs. I’m talking about its effects in Cancer domain as co
adjuvant therapy in synergy (or not) with Ciclo oxigenase inhibitors like
Nimesulide.

However, it seams that, lattely, Statins are starting to be also famous in
AIDS.

I’ve tried Pub Med and I found, at least 3 surprising scientific papers that
may illustrate my conviction.

a) Statins inhibit HIV-1 infection. PMID: 15314078.

b) Statin compounds reduce HIV 1 replication. PMID: 15479847.

c) Lovastatin potentiates antitumor effects of saquinavir against human
lymphoma cells PMID: 15547765.

Any thoughts about these experiments?

Thanks.

Karl

posted by admin in Uncategorized and have No Comments

Editor of Rubber Chemistry and Technology on condoms

Editor of Rubber Chemistry and Technology, Dr. C. Michael Roland of the
U.S. Naval Research Laboratory in Washington D.C., spoke about his
research on "intrinsic flaws" in latex rubber condoms and surgical gloves
(published in Rubber World, June, 1993).

Roland said that what I am about to relate is "common knowledge among good
scientists who have no political agenda."

Electron microscopy reveals the HIV virus to be about O.1 microns in size
(a micron is a millionth of a metre). It is 60 times smaller than a
syphilis bacterium, and 450 times smaller than a single human sperm.

The standard U.S. government leakage test (ASTM) will detect water leakage
through holes only as small as 10 to 12 microns (most condoms sold in
Canada are made in the U.S.A., but I’ll mention the Canadian test below).
Roland says in good tests based on these standards, 33% of all condoms
tested allowed HIV-sized particles through, and that "spermicidal agents
such as nonoxonol-9 may actually ease the passage."

Roland’s paper shows electron microscopy photos of natural latex. You can
see the natural holes, or intrinsic flaws. The "inherent defects in
natural rubber range between 5 and 70 microns."

And it’s not as if governments don’t know. A study by Dr. R.F. Carey of
the U.S. Centers for Disease Control reports that "leakage of HIV-sized
particles through latex condoms was detectable for as many as 29 of 89
condoms tested." These were brand new, pre-approved condoms. But Roland
says a closer reading of Carey’s data actually yields a 78% HIV-leakage
rate, and concludes: "That the CDC would promote condoms based on [this]
study…suggests its agenda is concerned with something other than public
health and welfare." The federal government’s standard tests, he adds,
"cannot detect flaws even 70 times larger than the AIDS virus." Such tests
are "blind to leakage volumes less tha one microliter – yet this quantity
of fluid from an AIDS-infected individual has been found to contain as
many as 100,000 HIV particles."

As one U.S. surgeon memorably put it, "The HIV virus can go through a
condom like a bullet through a tennis net."

It’s the same story with latex gloves. Gloves from four different
manufacturers revealed "pits as large as 15 microns wide and 30 microns
deep." More relevant to HIV transmission, "5 micron-wide channels,
penetrating the entire thickness were found in all the gloves." He said
the presence of such defects in latex "is well established."

For Canada, the story is the same. A standard Health and Welfare Canada
test of condoms manufactured between 1987 and 1990, based on stringent
tests of pressure, leakage, and volume (as in the U.S., there is no effort
to examine micron-level leakage), reported that an astonishing 40% of the
condoms tested failed at least one of the tests. Tests in 1991 showed an
"improved" 28% rate.

posted by admin in Uncategorized and have Comments (15)

New animal protein concentrated powder

New animal protein concentrated powder
with omega 3 and 6 for human direct consumption

MATREL S.A.C. Peruvian company compromised with the investigation and
development of the technological and nutritional studies, presents
PROTEINOL – protein concentrated powder with oily acids omega 3 and 6
– to be used as partial substitute of other animal protein sources, of
equal or minor nutritional value and of major costs.

INTRODUCTION
The proteins, due to their shortage and the importance that they have
like food, have turned nowadays into the principal area of attention
of the majority of food technologists arround the world. Food
products, rich in these macromolecules, like meat, milk and eggs, are
scanty in the majority of the countries in routes of development, and
besides, for being the costliest of producing, are the most difficult
to acquire.

The lack of animal proteins of low cost that could be used for human
direct nourishment in the countries in routes of development, have
allowed MATREL S.A.C. to develop an innovative technology to elaborate
protein concentrates with omega oily acids obtained from hydrobiologic
resources for human consumption, product that has been named
PROTEINOL.

TECHNOLOGY OF EASY APPLICATION

FIGURE 1 : General Flow for PROTEINOL’s production

FORMS OF CONSUMPTION

PROTEINOL can be consumed directly or be tried as ingredient in food
preparation. PROTEINOL’s advantage, besides its high concentration of
proteins, is that it shows an excellent content of essential amino
acids for the human nutrition, determined by the level and type of
amino acids that constitute the above mentioned proteins. PROTEINOL’s
nutritional value is compared with other high quality animal proteins
like those from milk, egg and meat.

NUTRITIONAL COMPARISONS

The hydrobiological resources and their derivatives are used often as
source of animal protein, nevertheless erroneously they are compared
with vegetal proteins, like soy bean for example.

PROTEINOL as a source of animal protein, has been compared with other
protein sources of the same origin emphasizing its nutritional
kindness across the content of amino acids and the digestibility of
the same ones. The results of the above mentioned comparison are
showned in FIGURE 2

FIGURE 2

In the human nourishment, the need to consume proteins is not only
owed to that their amino acids components are needed to construct the
proper proteins of every person; many of the amino acids have besides
other missions in the organism as for example:

Formation of important substances as:

The vitamins niacine (tryptophan), tiamine (tryptophan) and folic acid
(glutamic acid ).
The hormones adrenaline and thyroxine (thyrosine and its predecessor
phenylalanine).
The melanine pigment (thyrosine).
Complex Fats (methionine, serine).
Glutathione, which intervenes in processes of neutralization of toxins
(glutamic acid, cisteine and glicine).
Carnosine, of the muscles (lisine).
Creatine, muscular source of energy (arginine, glicine, methyonine).
Bases of the nucleic acids (glicine, aspartic acid), purines
(histidine).
Co-factors NAD-NADP, essential in the energetic metabolism
(thryptophan).
GABA, of cerebral action ( glutamic acid).
Serotonine (thryptophan), neurotransmisor that probably intervenes in
the cerebral control of the appetite, diminishing the desire to
consume carbohydrates.

On the other hand, biological studies realized in PROTEINOL have
showed high contents of oily acids of the type omega. Habitually it is
not necessary to consume especially any type of fat; the organism can
obtain them across another nutrients like carbohydrates. Nevertheless,
the oily acids omega cannot be synthesized for what they have to be
consumed with the food. The omega are a part of the group of poli
unsaturated and gather in crowds in two families Omega-3 and Omega-6.

Inside the oily essential acids in PROTEINOL’s fat, there are present
the oily unsaturated acids omega 3, being the most representative the
EPA (eicosapentaenoic acid), the DHA (docosahexaenoic acid). The
family of omega 3 have an important role in the development and
physiology of the human being, due to the fact that they form a part
of the structure of the neurons, brain, retina and peripheral nerves.
Omega 3 are supplemented during the foetal stage for the mother across
the placenta and, on having been born, for the human milk. The family
of omega 6, is essential covering each of the cells of the organism
and it takes part in hormonal and immunological activities. They are
indispensable to support the skin in healthy condition, helping it
keep its soft and flexible beside protecting it from infections,
regulating its temperature and water loss.

A person in good conditions of health has big accumulations of omega 3
in the brain tissue, in sight tissue and in semen. Nevertheless the
principal advantages of these oily acids take root in that they help
to a good development and growth of the brain tissue, attacking the
cancer, development of the sight and functions of the cellular tissue,
help to regulate the blood pressure, the viscosity of the blood,
cardiovascular diseases, trombosis, inflammations and arthritis.

PROTEINOL’s utilization of false flying fish (Prionotus stephanophrys)
and of giant squid (Dosidicus gigas) in the formulation of babyfood,
have allowed to demonstrate its nutritional and sensory kindness, and
the reduction in the costs of the above mentioned food.

CONCLUSIONS
For all written before, PROTEINOL can be included in diverse products
Food Assistance Programs demand in some countries in routes of
development, as source of animal protein. The incorporation of the
PROTEINOL will allow to support or to improve the nutritional quality
of the final products without altering its smell, flavor or
appearance, supporting the nourishing customs of the population in
situation of total poverty and extreme poverty and incorporating in
their diet the marine resource.

October, 2004
MATREL
www.matrelfoods.com
Republica de Panamá 5893 Miraflores-Lima Perú
mat…@millicom.com.pe

posted by admin in Uncategorized and have No Comments

Latex IS PROTECTION…..against snails

You can throw your useless old condoms in the garden to get rid of snails.

Toxicity of Euphorbia milii latex and niclosamide to snails and nontarget
aquatic species.

Oliveira-Filho EC, Paumgartten FJ.

Laboratory of Environmental Toxicology, The National School of Public
Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ 21045-900, Brazil.

The toxicity of Euphorbia milii molluscicidal latex and niclosamide (NCL)
to target snails (Biomphalaria glabrata and Biomphalaria tenagophila) and
nontarget aquatic organisms is evaluated. Planorbidae snails were killed
by very low concentrations of lyophilized latex (48-h LC(50), mg/L: B.
glabrata, 0.12; B. tenagophila, 0.09; Helisoma duryi, 0.10). Latex was
less toxic (48-h LC(50) or EC(50), mg/L) to oligochaeta (Tubifex tubifex,
0.31), planktonic crustacea (Daphnia similis, 0.38; C. dubia, 1.07;
Artemia sp., 0.93), and fishes (Danio rerio, 0.96; Poecilia reticulata, 1.
39), and considerably less toxic to Ampullariidae snails (Pomacea sp. ,
10.55) and frog tadpoles (Rana catesbeiana, 7.50). Latex (up to 100 mg/L)
was not toxic to bacteria (P. putida and V. fischeri), algae (Selenastrum
capricornutum and Chlorella vulgaris), and mosquito larvae (Anopheles
albitarsis, Aedes aegypti, Aedes fluviatilis). NCL was very toxic (48-h
LC(50) or EC(50), mg/L) to Planorbidae snails (B. glabrata, 0.15, B.
tenagophila, 0.13; H. duryi, 0.10), T. tubifex (0.11), crustacea (D.
similis, 0.19; Ceriodaphnia dubia, 0.47; Artemia sp. 0.18), fishes (D.
rerio, 0.25; P. reticulata, 0.29), R. catesbeiana (0.16), and Pomacea sp.
(0.76). NCL was toxic to bacteria, algae (96-h IC(50), mg/L: S.
capricornutum, 0.34; C. vulgaris, 1.23) and slightly toxic to mosquito
larvae. In conclusion, E. milii latex, as compared with the reference
molluscicide niclosamide, presents a higher degree of selectivity toward
snails which are intermediate hosts of Schistosoma trematodes. Copyright
2000 Academic Press.

PMID: 10903832 [PubMed - indexed for MEDLINE]

posted by admin in Uncategorized and have Comments (3)

Thoughtful dialogue on gay men's health challenges.

Thoughtful dialogue on gay men’s health challenges
http://groups.yahoo.com/group/GayMensHealthSummit/messages
http://www.healthsummit2004.org/programming.htm

  The Gay Men’s Health Summit is a discussion list for emerging issues
in the gay men’s health movement.

Contributors regularly post articles important to
advocates,
health educators, and
service provider
or requests for information on particular topic or focus area.

  Created at the Gay Men’s Health Summit in Boulder, Colorado in 1999
by Ric Kasini Kadour and Mike Henry, the GMHS eList exists to
foster dialogue and information sharing among those people who make up
the gay men’s health movement.

  …the primary communication tool of the Gay Men’s Health Summit and
the Gay Men’s Health Movement.

This list was created out of the 1999 Boulder Gay Men’s Health Summit
and is maintained by Ric Kasini Kadour kasini at ix.netcom.com

This multi-purpose list will allow summit participants and other
professionals involved in service delivery to gay men to keep in touch
and communicate with each other.

This list is a great way to:
1. Communicate about tasks identified at Boulder Summit
2. Seek other participants/interested parties to help in those tasks
   as well as tasks that are identified as Summit 2000 is planned.
3. Ask questions of the list members about a wide variety
   of health-related programming and service delivery methods.
4. Announce program successes
   and failures
   so that others may learn and grow from your knowledge.
5. Post announcements about Summit 2000,
   other conferences,
   meetings,
   published documents,
   reports, and
   events in the realm of gay men’s health
6. Report on progress on the Boulder Summit Outcome Report objectives.

If you have any questions about the purpose of the list or the
use of the list… kasini at ix.netcom.com

http://groups.yahoo.com/group/GayMensHealthSummit/messages
http://www.healthsummit2004.org/programming.htm

posted by admin in Uncategorized and have Comments (9)

A CRITICAL ANALYSIS OF THE HIV-T4-CELL-AIDS HYPOTHESIS

http://groups.msn.com/EVERYTHINGABOUTT4CELLS/articles.msnw?action=get…

posted by admin in Uncategorized and have No Comments

First hand experience

i just joined the group, and i used to have the thinking about aids and hiv
that the vast number of people do…i became positive(whatever that means)
in NOV. of 96..i went to my doctor for strept throat..which i have always
faithfully gotten every november/december sence i was 10..i went in and he
checked my throat…and asked if i have ever been tested for hiv..i said
no..he tested me..even though i had no idea what that would have to do
with my strept throat that i had always gotten every year for 13 years be4
this…..so i took it and it came back positive..i had two kids who were 2
and half years old..and 7 months old. at that time…i became
depressed….and sad..my doctor wanted me to take hiv meds. which like a
lamb being led to slaughter i did…2 months later i was in the
hospital…sick as a dog…that was the first time in my life i had ever
been sick enough to be put in the hospital….sence then i quit all
meds..that was in early 1997…and sence then i have felt fine.i eat
right…which is IMPORTANT!!!! for anyone!!..and changed my thinking from
i am to i wont!!!…i take care of myself…….i listen to my body…and
stay active…the last viral load i had was..38,000..whith t-cells..of
246……and i feel vvery good..but my doctor on the other hand says those
or bad numbers…and i told him…he was doing bad medicence…i belive
my..our bodys let us know when something is wrong with us or it!!!…i
just want to let everyone living with…hiv.or whatever it is…..(as i am
not really sure)….to listen to there bodys rather than a doctor…just
take care of urselfs…eat right…live right..think right…i do go to
doctors but not for my hiv..i dont belive when i am not feeling well its
becasue of hiv…my last visit with my.."hiv" doctor he told me my
athlete’s feet was because of my condition????…..so i left and bought
some foot cream and it went away rather quickly…all ican say is what i
have said be4..take care of urself….and i would like to thank
Christy!!!!….as i learned alot!!!!. of things about this virus i would
have never learned from my doctor..!!!!!!!……thank u so much for all u
have shared and i hope everyone is well!!!!

posted by admin in Uncategorized and have Comments (4)

LOW CD4+ T LYMPHOCYTE COUNTS

http://groups.msn.com/EVERYTHINGABOUTT4CELLS/articles.msnw?action=get…

posted by admin in Uncategorized and have No Comments

Smart HIV Test is Dumb After All

Reprinted from Credence Publications November 25, 2000,
http://www.creedence.org
Smart HIV Test is Dumb After All
By Steven Ransom
 
“When the gloss is stripped away, the “100% accuracy” confidently
trumpeted for the new Smart Test is completely untrue. As with any other
rapid test, it might show positive results on patients with other diseases
or with high amounts of non-specific antibodies…”
 
===
 
Inaccurate HIV Test Spells Potential Disaster for Argentina and South
Africa
 
A quick and easy HIV diagnostic tool known as the “Smart Test” is the
latest product being vigorously promoted by World Diagnostics Inc. The
company’s web page (http://www.worlddiagnostics.com/news_f.htm) includes
the following headlines: “WDI’s HIV Tests Approved by Argentine
Government” and “South African Government Validates HIV Rapid Test.”
 
“We anticipate that the [SA] business will add significantly to WDI’s
revenue and growth over the next twelve months… shipments are to begin in
October to supply more than 500 government-run clinics with the rapid HIV
diagnostics test… WDI’s rapid HIV test is a 100 percent positive
predictor,” reports Ken Peters, President and CEO of WDI.
 
Confident corporate statements, these may well be. Privately however, Dr
Martin Muy, the Technical Affairs Vice President of WDI, is not so
confident. And in a series of email correspondences, what he has admitted
to Credence personnel spells potential medical disaster for South Africa
and other recipient nations of the latest Smart Test. Before examining Dr
Muy’s statements in more detail, let us briefly examine the inherent
weakness fundamental to all HIV predictor kits. Let the reader be assured
that a medical background is not necessary in order to grasp the key
elements to the AIDS test controversy.
 
In no instance does any HIV test measure the presence of a virus. The test
measures only raised levels of antibody activity in the blood sample
supplied. Raised levels of antibody activity are a normal occurrence in
the blood, and indicate primarily a well-functioning immune system.
Scientific literature records in excess of 60 separate medical conditions
that can raise sufficient levels of antibody activity in the blood to
trigger a “false” positive reading. These separate conditions include flu,
flu injection, malaria, tetanus injection, Hepatitis A and B, Hepatitis
injections, renal failure, haemophilia (through the introduction of Factor
VIII into the bloodstream), organ transplant, alcohol and drug use, recent
viral infections and even pregnancy. These positive readings are then
misinterpreted by the AIDS orthodoxy as indicating the presence of HIV. As
a result of this misinterpretation, men, women and children across the
world are being wrongly as HIV positive.
 
Quite shockingly, the above anomalies are well known to the major
manufacturers of “HIV test kits,” and all leading brands carry with them a
statutory disclaimer. The Abbott Laboratories AXSYM ELISA test for
instance contains the following wording "At present, there is no
recognised standard for establishing the presence or absence of antibodies
to HIV-1 and HIV- 2 in human blood.”
 
To make matters worse, these manufacturers advise that confirmation of
their test can be arrived at only by employing at least two other
independent tests, and not their own. This is an excellent example of
passing the buck, transferring ultimate responsibility and potential
litigation difficulties onto a test product conveniently outside of their
own manufacturing stable. To compound the issue, the independent
“confirmatory” tests advised by these manufacturers all carry a similar
disclaimer. Thus, a test admitting that it cannot determine the presence
of HIV is being “corroborated” by two other equally imprecise antibody
detection tests. In simple terms, a positive reading from any of these
tests carries little or no diagnostic value. What comfort then for the
thousands upon thousands of individuals who have been diagnosed HIV
positive via these tests? Their lives have been quite needlessly ruined.
Those who are battling for these simple facts to reach the wider public
domain will know that the inaccurate nature of the HIV test represents
only a small proportion of the inconsistencies in the AIDS and HIV
debate—the global phenomenon that is increasingly becoming known as the
greatest medical fraud of the 20th and 21st centuries.
 
And in the case of World Diagnostics International, when the gloss is
stripped away, the “100% accuracy” it so confidently trumpets for its
Smart Test is completely untrue. WDI’s 100% accuracy statement was arrived
at by “confirming” their test with the Abbott Axsym system, the Pasteur
Sanofi ELISA system, and then by Western Blot analysis.
 
The Abbott Axsym system we already know about. With regard to the Pasteur
Sanofi product, a Mr Potter from Bio-Rad UK (a subsidiary of the
organisation which has since bought out Pasteur Sanofi) admitted that
illnesses such as malaria, typhoid and TB could show positive on their
tests. He admitted also that their kit should not be used as confirmation
of a positive result. Mr Potter further stated that as yet, no company has
any diagnostic tool that will accurately predict HIVpositive status.
Concerning the validity of the Western Blot test, head of the UK Public
Health Laboratory Services Dr Phillip Mortimer has admitted that this test
is not appropriate for use in confirmatory testing for HIV, and has
abandoned the use of Western Blot.
 
Considering these factors, and the extent to which WDI is now contributing
to world-wide HIV testing procedure, Credence Publications approached WDI
under the assumed name of “Protec Diagnostics,” and posed some delicate
questions with regard to the possibility of false HIV positives being
delivered by their Smart Test. Dr Muy is the Technical Affairs Vice
President of WDI, and a former Senior Product Development Manager for
PharmaCorp, and engaged previously by such companies as BPL (UK), Schering
Plough (USA), Ortman Biomedics (Switzerland) and Epitope (USA). Muy
admitted to us the possibility of false positives, stating “…the
disclaimer ‘false positive’ means that this rapid device—as with any other
rapid device in the market—might show a positive result on certain samples
coming from patients with other diseases, i.e, auto-immune diseases, or
with high amounts of non-specific antibodies as happens in some
diseases.”
 
When we asked how the WDI test could possibly be validated by tests that
in themselves were equally unspecific, Muy could offer no guarantees and
replied “I have to be honest with you; our rapid tests have the same
drawbacks as the ELISA tests.”
 
Dr. Martin Muy, Technical Affairs Vice President of WDI, admitted the
possibility of false positives, stating “…the disclaimer ‘false positive’
means that this rapid device—as with any other rapid device in the
market—might show a positive result on certain samples coming from
patients with other diseases, i.e, auto-immune diseases, or with high
amounts of non-specific antibodies as happens in some diseases.”
 
In their thousands, WDI tests are now headed for parts of the world where
the prevalent illnesses such as TB, malaria, cholera, poor sanitation and
poverty related disease all elicit high levels of antibody activity in the
bloodstream. The potential for misdiagnosis is rife. Simple medicines for
simple illnesses will be overlooked, as thousands are quite falsely
diagnosed HIV positive. These misdiagnosed unfortunates will then be fed
that country’s generic versions of the latest AIDS drugs, in themselves
highly toxic, and having the well-documented capacity to bring about
immune-destroying illnesses and eventual death. More than likely, they
will then go on to die a death that will quite wrongly be catalogued as
“death from AIDS.”
 
We then asked how anyone could accurately and with full peace of mind
pronounce a HIV positive status upon anybody. Dr Muy replied: “Regarding
your question, I personally would not be satisfied with a rapid test nor
with an ELISA test; that comes to a matter of ethics.”
 
So one is bound to ask: where are ethics on the “to do” list at WDI? At
the time of writing, the latest headline on their web page announces an
AIDS catastrophe “set to engulf Russia.” Having calculated the population
of this vast continent, and despite the unnecessary misery, suffering and
death WDI and their naïve purchasers may cause, it seems that World
Diagnostics Inc are now set to clean up North as well as South.
 
When asked how anyone could accurately and with full peace of mind
pronounce an HIV positive status upon anybody, Dr Muy replied: “Regarding
your question, I personally would not be satisfied with a rapid test nor
with an ELISA test; that comes to a matter of ethics.”
 
Steven Ransom.
Credence Publications

posted by admin in Uncategorized and have No Comments

Viral Load and the PCR

Viral Load and the PCR
why they can’t be used to prove "HIV" infection
by Christine Johnson
Home 
Note: The information on this website is presented for educational
purposes and
is not a substitute for the advice of  and treatment by a qualified
professional.
This document was provided by
Continuum Magazine
VOL. 4 No. 4
"Biotechnology’s version of the Xerox machine"— that’s what Forbes
magazine called the polymerase chain reaction (PCR). This revolutionary
technique enables a scientist to take a sample containing a minute amount
of DNA and replicate that DNA sequence until there are a million copies
instead of just one or two.
Kary Mullis, inventor of PCR, won a 1993 Nobel prize for his
billion-dollar invention, which has become indispensable to any genetics
lab. It is ironic that one of the first applications of PCR was to detect
HIV, considering that Mullis himself doesn’t believe his invention is
capable of this. Mullis states the problem is PCR is too efficient – it
will amplify whatever DNA is in the sample, regardless of whether that DNA
belongs to HIV or a contaminant. And how do you decide which part of the
amplified material could be HIV and which part the contaminant(s), if you
couldn’t detect HIV in the sample without using PCR?
One of the main arguments against the HIV/AIDS hypothesis is that, when
employing traditional methods of virus detection, HIV has never been
inferred in significant amounts in people with AIDS. Virus culture, for
instance, has been adequate to find other viruses, but not HIV. Why not?
When virus culture is employed to detect HIV, HIV is never seen or even
looked for in the cultures. Its presence is measured by very indirect
methods: assays for detection of reverse transcriptase or a p24 protein,
neither of which is specific for HIV. Indirect methods would not be
necessary if a significant amount of HIV were there to begin with. In
other words, if a meaningful amount of HIV were present, the time-honored
laboratory techniques should be able to find it. They can’t. Now we need
not only PCR, but continuous modifications and improvements on PCR, in
order to try to find HIV.
This is how the idea of "viral load" came about, inspired by two spates of
scientific papers that claimed HIV is busily replicating by the billions:
initially, papers claiming HIV was "hiding in the lymph nodes,"1,2 and
more recently, the Ho and Wei papers.3,4 The latter studies attempted to
measure "viral load" at a given point, after which "antiviral" drugs were
administered to the patient. The drugs were supposed to prevent
replication of any new HIV, and the viral load would decrease accordingly.
However, within a few days, the remaining virus would mutate into a form
resistant to the drugs, and in a few weeks the viral load would return to
its pre-treatment levels. Applying a mathematical formula to this dynamic,
the rate at which the virus replicates was allegedly determined.
Hence was born what I call "Dr. Ho’s kitchen sink theory". According to
Ho, billions of copies of HIV are being made every day, which infect
billions of T4-cells. These T-cells are destroyed not by HIV, but by the
immune system. They are replenished every day, but over the years, the
immune system loses ground and HIV finally wins. This process was likened
to a sink with the drain open, the water pouring in from a tap (new
T-cells being made) at a slightly lower rate than it drained away
(infected T-cells being destroyed).
It is most important to note that the viral load studies all rely
completely on PCR and related techniques. This article will discredit PCR
as an accurate method of determining HIV infection, which will in turn
cast doubt on any conclusions about HIV that have been made based on PCR
techniques.
 SOME BASICS ON DNA
PCR takes advantage of certain fundamental properties of DNA. DNA (as well
as RNA) is a nucleic acid, and nucleic acids are composed of nucleotide
"building blocks". DNA exists as two complementary strands arranged in a
double helix formation (two intertwining spirals). These strands are made
up of many nucleotides hooked together to form a long chain of DNA.
The nucleotide molecule has three different parts: the phosphate and the
sugar (which form a backbone or a ribbon-like structure), and the base.
There are four types of bases: A, T, C, and G (adenine, thymine, cytosine,
and guanine). These bases are attached to the backbone, which is wound in
the familiar double helix.
The bases on one strand bind to the bases on the other strand, and this
gives DNA its stable double helix structure. (Think of the two strands as
forming a zipped-up zipper.) The distinct nature of an organism’s DNA code
depends on the order, or sequence, of the bases along the DNA chain.
There are special rules about how bases form chemical bonds with other
bases: an A will only bind to a T, and a C will only bind to a G. A base
on one strand binding to a base on the other strand is called a
"complementary base pair". This rule of complementary base pairing is what
gives DNA its ability to replicate itself exactly.
Each time a cell divides, it has to make a copy of its DNA for the new
cell. The DNA double-strand first "unzips" itself into two separate
strands. Each single strand serves as a template, or pattern, from which
to make a new copy of its complementary strand. (So, strand #1 serves as a
pattern to make a new copy of strand #2, and vice versa.) The single
strand then incorporates new nucleotide building blocks from the
surrounding medium according to the rule of complementary base pairing. In
other words, an available A on the single strand will grab onto a T
nucleotide, a C will grab a G, and so on until the entire opposite strand
is duplicated. At the end of this process, the two original strands zip
themselves up again, and the two copied strands serve as DNA for a new
cell.
How PCR works
The theory of HIV says it, like other suggested retroviruses, contains RNA
but no DNA: when HIV is said to infect a cell, the reverse transcriptase
enzyme is thought to transform the RNA into complementary DNA, which is
then inserted into the host cell’s DNA.
Therefore, if PCR is used to analyse human tissue for the presence of HIV,
it would be looking for only a short segment out of the entire cellular
DNA strand. This short segment represents the genetic material proposed
for HIV, that in theory has been incorporated into the DNA of the cell.
(Viral load studies try to look for cell-free HIV. Even here, PCR is only
looking for part of HlV’s entire proposed genetic package, or genome, not
an entire virus.)
 Obviously, it is necessary for the primers to be specific to HIV. Whether
the PCR will make an amplified product (a "positive PCR") depends on
whether the primers you add match part of the DNA in the target specimen.

Below, we will see that the specificity of the primers for HIV is in
doubt. Even if the primers were specific to HIV, if similar sequences are
present in the target, the primers, under lax conditions, will form
hybrids with (or bind) related sequences that are less than a perfect
match.
They will then prime the polymerase, which starts the amplification
procedure, even though no HIV was present to begin with.
PCR works in the following fashion:
Step 1: Heat the template
A long piece of DNA containing the smaller fragment to be copied is
heated. The two strands can be "melted" apart at elevated temperatures,
and will slowly come back together upon cooling ("annealing"). The two
separated strands are complementary to each other. They serve as templates
for the new strands.
Step 2: Add the primers
Something called a primer is necessary for the next step. Primers are
nucleotides that form a short sequence of new strand. Primers are designed
to be complementary to a known sequence which is part of a larger
sequence, and thus where the primers will bind (or hybridise) is known.
The primers attach to each end of the DNA segment that is to be copied
(the segment that represents HIV’s proposed genetic material). The primers
serve two purposes: a) to mark each end of the targeted segment so only
that segment will be amplified, and not the entire strand, and b) to get
the duplication process started. The new strands are built block by block
by the action of an enzyme called polymerase. The polymerase builds a new
DNA strand alongside an existing strand. The polymerase will not work
unless the old strand (the template) already has on it a few nucleotides
forming a short sequenceof new strand (the primer). (If you ever see a
reference to "template-primers," this is what they’re talking about.)
In other words, the polymerase can only form a new strand if the new
strand has already partially been formed. In nature, when your own DNA is
duplicating itself, other enzymes called DNA primases build the primer
onto the old strand.
Once the polymerase gets going, it crawls along the single DNA strand (the
template) adding to it the nucleotide building blocks one by one. The
primer ends up being part of the newly-made strand.
In nature, polymerases pull the DNA strands apart while they build the new
DNA strand. This is how duplicate copies of DNA are made so that cells
like blood and skin cells can divide into two new cells, a process
essential for life.
Step 3: Amplify
Once again, after melting and then annealing the primers, the polymerase
enzyme copies the DNA beginning at the primer, making a new copy of each
target segment. This process is repeated for as many as 30-40 rounds.
During each cycle, the amount of segments doubles, so two segments become
four, four become eight, then 16, etc. By the end of the process,
approximately a million copies of the original segment have been made. Now
you have a whole lot of DNA, where originally you had only a minuscule
amount. This is why PCR is referred to as being able to find a "needle in
a haystack."
USING PCR TO FIND HIV
A problem for the HIV hypothesis was that, even with the use of standard
PCR, researchers could not find much, if any, HIV in persons with AIDS
diagnoses. To resolve this paradox, the authors of the new "viral load"
papers came up with two modifications of PCR, which they claimed were much
more efficient at finding HIV. These were the QC-PCR and the branched DNA
test (bDNA). And suddenly – eureka! – billions of copies of what was
believed to be HIV were found. The contradiction here seems to have
escaped the authors of these papers: Why would such powerful new tests be
needed at all to find a microbe that is present in the billions?
Traditional methods should suffice.
QC-PCR
This is the test used in the above-mentioned papers by Anthony Fauci
(Pantaleo) and Ashley Haase (Embretson), which claimed HIV was "hiding in
the Iymph nodes." These papers were accepted as fact, even though QC-PCR
was, and remains, an unvalidated technique.
Mark Craddock, of the University of Sydney (Australia), explained the
principles of and problems with QC-PCR as follows:8
"PCR mass produces fragments of DNA. You start with a small amount of DNA
and after each PCR cycle, the amount of DNA you have is between one and
two times the amount at the beginning of the cycle. Thus, the amount of
DNA you have to study increases exponentially. The fact that the PCR is an
exponential growth process means that experimental errors will also grow
exponentially, so you need to be very careful about what you do with the
process.
"A number of people have decided that it should be possible to estimate
the amount of DNA present in a sample by using PCR. This is the so-called
quantitative competitive PCR. The idea is to add to the sample to be
estimated a known amount of similar but distinguishable DNA and amplify
both together. The assumption is that the relative amounts of the two
products should stay the same, and hence you can work out the size of the
sample you started with by knowing the ratio of the two, determined by
observation when PCR has produced enough of both to measure, and how much
control DNA was added.
"What is absolutely crucial is that the relative amounts of the test DNA
and your known control must remain exactly equal. Close is not good
enough. The slightest variations will be magnified exponentially and can
produce massive errors in your estimate.
"The difficulties in using PCR quantitatively were pointed out by Luc
Raeymaekers in the journal Analytical Biochemistry in 1993. He noted
published papers on QC-PCR contain data that show that the fundamental
assumption that the relative sizes of the samples remain constant is not
met in practice. Despite this, HIV researchers continue to use PCR to
quantify viral load. There is simply no way of knowing whether a given
estimate is correct or is 100,000 times too high!"
Todd Miller calls QC-PCR the "latest fad in science" and agrees that if
the relative amounts of your test DNA and your known control are not
equal, there is one thing you can say for sure about the estimate of your
starting target (the amount of proposed HIV RNA in the patient’s blood
sample): It will be wrong.
How did QC-PCR, with all its flaws, become an acceptable HIV test? Miller
explains:
"The way this situation has manifested itself in modern science is like
this: First some people spend a lot of time trying to get this test to
work, and if they’re lucky, end up publishing papers about caveats in the
procedure. Second, others happen to get the test to give them an answer
that "makes sense" and publish their data as a significant contribution to
the field. Third, because of its relative newness and arcane nature, it
remains as quasi-accepted with many passive sceptics and a few users.
However, most who use it are more interested in their own pet phenomenon
than in the mechanics of the reaction."
bDNA
BRANCHED DNA PCR
This is the test used in Ho’s paper. Though it is not, strictly speaking,
PCR, it is referred to as such since it incorporates PCR-type technology.
The difference is that bDNA amplifies the signal, not the target. That is,
regular PCR makes more of the target so you can find it, whereas bDNA sort
of shines a bright spotlight on it so you can see it better. Project
Inform was kind enough to send me the following explanation of how bDNA
works:9
"Copies of a DNA probe are attached to the wall of a small laboratory
vessel; then the sample is put in. [A DNA probe is a small piece of DNA
complementary to the target DNA sequence.] This probe binds to a certain
part of HIV RNA, if it is found in the sample, holding the RNA in the
vessel. Then another DNA probe is put in; one end of this attaches to
another part of the HIV RNA. The other end of the second probe has many
branches and each branch ends with a "reporter" chemical that, under
certain conditions, will produce light, which can be detected by
laboratory equipment. Each molecule of HIV RNA can attach to one of these
branching structures and hold on to a small number of light sources, not
just one. In this way, very small amounts of the target RNA can be
detected, without the need for PCR amplification."
In his initial paper, Ho gave no data on the protocols for this test or
whether it was reliable. The reader was referred to two other papers that
were "in press". So, no data was available at that time to anyone who
wanted to verify this method. The data obtained from bDNA was confirmed by
QC-PCR, the details of QC-PCR being set out in a reference authored by
four co-authors of the Wei study, hardly what you might call independent
or objective researchers. In the tradition of HIV research, unproven
theories and faulty studies are accepted without question and incorporated
into the "conventional wisdom" before being properly validated. By then,
the damage is done, and if subsequent flaws are discovered it hardly
matters.
The mechanics of bDNA are complex: Five different hybridisation reactions
are going on. Hybridisation is a standard technique wherein a DNA probe is
put into a sample and will bind to any complementary segments it finds.
It’s another indirect test, and it has a lot of problems. According to
molecular biologist Bryan Ellison, "The only time molecular biology works
is if you purify things first. There’s always the possibility of
cross-reactions, especially when you put your probes into a big soup of
proteins" (which is exactly what the target blood sample is).
Duesberg pointed out the following: After making the appropriate
adjustments to his calculations, Ho himself later found that more than
10,000 viruses inferred by the bDNA assay used in his Nature paper would
actually correspond to less than one infectious virus, leading one to
wonder what it is that is actually being measured on these tests.10 Yet
these speculative and unvalidated papers have been accepted as gospel
truth!
In Ellison’s mind, Ho’s study is "Pure fantasy. There’s never been a paper
that shows viral load."
 The Problems with PCR
THE ACCURACY OF PCR HAS NEVER BEEN VERIFIED BY A PROPER GOLD STANDARD
To find out if any diagnostic test for HIV infection actually works, it is
necessary to verify the test with an independent gold standard. The only
proper gold standard for this purpose is HIV itself. In other words, the
results of your experimental test, whether it’s PCR or anything else, must
be compared to the results of virus isolation in each sample tested. If
virus is actually found in each patient with a positive PCR, and no virus
is found in each patient with a negative PCR, then you could say PCR is
extremely accurate for detecting HIV.
The concept of virus isolation as a gold standard is particularly
important in the case of HIV, since HIV has been extremely difficult, if
not impossible, to define in genetic or molecular terms. Even if anyone
had ever accomplished virus isolation for HIV11, it has never been used as
a gold standard for any HIV diagnostic test, including PCR. As it stands
right now, bDNA uses QC-PCR as a gold standard; QC-PCR uses regular PCR as
a gold standard; regular PCR uses antibody tests as a gold standard, and
antibody tests use each other. I have noticed time after time that studies
which are "verifying" an HIV antibody test will invariably state that they
evaluated the performance of their test on samples which were known to be
TRUE-POSITIVE or TRUE-NEGATIVE. How did they know this? It’s simple:
Without a gold standard, they didn’t.
It is sometimes argued that "studies have shown" these tests to agree with
each other or confirm each other’s findings, and therefore they must be
correct. This is not rigorous scientific thinking. Sometimes you can get
the results of different tests to agree with each other, but that does not
prove anything – no more than it would prove if five criminals all agreed
that they were somewhere else when the bank was being robbed.

posted by admin in Uncategorized and have Comments (4)